Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RWD domain-containing protein 1 (RWDD1) is a human protein and member of the RWD domain protein family, and may be a type of intrinsically unstructured protein. RWDD1 is ubiquitously expressed in a wide range of tissues, and its key biological role is to protect DRG2 from proteolytic degradation. It also participates in the regulation of androgen receptor activity and is implicated in cytoplasmic translation. Reduced RWDD1 expression has been observed in aged or oxidatively stressed thymic tissue in mice. There is an association of RWDD1 with Potocki-Lupski syndrome at the genetic level, but its direct involvement in human disease is not established. Currently, no drugs target RWDD1, and it is not considered a traditional therapeutic target such as a receptor, enzyme, or transporter.
Not applicable; no drugs or tool compounds reported to act directly on this protein.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RWD domain-containing protein 1 (RWDD1).